Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Trypsin-Chymotrypsin On Post-operative Pain After Single Visit Root Canal Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~* Egyptian healthy symptomatic both gender patients~* aged (18- 40) years old~* with no physical disability, facial paresthesia or psychological problems~* had mandibular first molars with symptomatic irreversible pulpitis and with normal appearance radiographically.~Exclusion criteria:~* The vulnerable group~* participants who un abled to read and fill the questionnaire,~* those who took preoperative analgesics 24 h prior to treatment~* those with known sensitivity to the drugs used in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Ibuprofen (Brufen) (Type: ACTIVE_COMPARATOR): Participants were handed Brufen (Ibuprofen) (Abbott chemical laboratories, Advil, USA) 600 mg 3 times daily for 3 days after meals in tightly sealed envelope with an included written paper contained the instruction for dose administration.
- Trypsin 5 mg Chymotrypsin 5 mg (Ambezim G) (Type: EXPERIMENTAL): Participants were handed Ambezim G (Trypsin 5 mg Chymotrypsin 5 mg) (Global Napi Pharmaceutical Company, Giza, Egypt) 3 times daily for 3 days one hour before meals in tightly sealed envelope with an included written paper contained the instruction for dose administration.
- Ibuprofen (Brufen) + Trypsin 5 mg Chymotrypsin 5 mg (Ambezim G) (Type: ACTIVE_COMPARATOR): Participants were handed Brufen (Ibuprofen) (Abbott chemical laboratories, Advil, USA) 600 mg 3 times daily for 3 days after meals and Ambezim G (Trypsin 5 mg Chymotrypsin 5 mg) (Global Napi Pharmaceutical Company, Giza, Egypt) 3 times daily for 3 days one hour before meals in tightly sealed envelope with an included written paper contained the instruction for dose administration.
- Placebo pills (Sugar pills) (Type: PLACEBO_COMPARATOR): Participants were handed postoperatively sugar pills (Placebo pills) (Department of pharmaceutics \& industrial pharmacy at Faculty of pharmacy Ain Shams University, Cairo, Egypt) 3 times daily for 3 days in tightly sealed envelope with an included written paper contained the instruction for dose administration.

Based on this trial design, predict the completion outcome and termination type (if applicable).